Shenzhen Weiguang Biological Products Co., Ltd. (SHE:002880)
China flag China · Delayed Price · Currency is CNY
26.51
+0.42 (1.61%)
May 12, 2026, 3:04 PM CST

SHE:002880 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
76.63369.81274.76252.3294.59332.1
Short-Term Investments
--153.3221.47--
Cash & Short-Term Investments
76.63369.81428.08273.77294.59332.1
Cash Growth
-81.04%-13.61%56.36%-7.07%-11.30%-29.58%
Accounts Receivable
405.26410.57284.26133.91208.46204.25
Other Receivables
25.8217.8417.085.054.651.62
Receivables
431.08428.41301.34138.96213.11205.87
Inventory
951.05882.73793.46672.98605.51421.68
Other Current Assets
9.185.474.7117.9819.9239.71
Total Current Assets
1,4681,6861,5281,1041,133999.36
Property, Plant & Equipment
622.47619.42691.09683.191,045785.22
Long-Term Investments
96.0479.5477.6786.7283.4969.17
Goodwill
19.2319.2319.2319.2319.2319.23
Other Intangible Assets
148.63150.77134.91136.875.1176.26
Long-Term Deferred Tax Assets
20.7422.729.9710.542.733.07
Long-Term Deferred Charges
52.9752.6628.3424.7522.7719.41
Other Long-Term Assets
1,2391,109808.65811.85194.6231.79
Total Assets
3,6673,7403,2972,8772,5762,004
Accounts Payable
101.74112.82137.1477.5533.1428.97
Accrued Expenses
51.2695.66135.98124.6675.5787.25
Short-Term Debt
269.5283111.4911.06100.0925
Current Portion of Long-Term Debt
47.6947.7314.7424.15--
Current Portion of Leases
--1.641.461.321.39
Current Income Taxes Payable
24.2935.679.6811.345.0814.88
Current Unearned Revenue
22.3721.840.763.27.82.4
Other Current Liabilities
104.55115.2111.3312.576.767.26
Total Current Liabilities
621.4711.94422.75265.99229.76167.15
Long-Term Debt
481.34493.22554.1483.71428.96-
Long-Term Leases
15.0914.7115.3216.0816.6617.04
Long-Term Unearned Revenue
56.9658.543.2746.7825.9223.98
Long-Term Deferred Tax Liabilities
11.0310.9711.7212.540.861.01
Other Long-Term Liabilities
5.585.586.056.056.056.05
Total Liabilities
1,1911,2951,053831.14708.2215.23
Common Stock
226.8226.8226.8226.8226.8226.8
Additional Paid-In Capital
563.49563.49563.49574.5574.5574.5
Retained Earnings
1,6531,6221,4211,2131,040967.42
Total Common Equity
2,4432,4122,2112,0141,8411,769
Minority Interest
32.5432.7632.8131.3626.7719.55
Shareholders' Equity
2,4762,4452,2442,0461,8681,788
Total Liabilities & Equity
3,6673,7403,2972,8772,5762,004
Total Debt
813.62838.66697.28536.46547.0243.42
Net Cash (Debt)
-737-468.85-269.21-262.69-252.44288.68
Net Cash Growth
------25.90%
Net Cash Per Share
-3.25-2.07-1.19-1.16-1.111.27
Filing Date Shares Outstanding
226.82226.74226.8226.8226.8226.8
Total Common Shares Outstanding
226.82226.74226.8226.8226.8226.8
Working Capital
846.53974.491,105837.72903.37832.2
Book Value Per Share
10.7710.649.758.888.127.80
Tangible Book Value
2,2762,2422,0571,8581,7471,673
Tangible Book Value Per Share
10.039.899.078.197.707.38
Buildings
--367.81341.65318.11269.13
Machinery
--798.15701.71590.44516.79
Construction In Progress
--42.2391.69536.42342.36
Source: S&P Global Market Intelligence. Standard template. Financial Sources.